Biotech · Public company · Phoenix, AZ, US
Creative Medical Technology Holdings, Inc.
Ticker CELZ · SEC CIK 0001187953
Track this companyFree. Adds Creative Medical Technology Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- CELZ-201 AdministrationPhase 2 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- CELZ-201-DDTPhase 2 · Chronic Low-back PainClinicalTrials.gov · fetched Nov 12, 2026
- Control GroupPhase 2 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 21, 2024ClinicalTrials.gov NCT06053242 · fetched Nov 12, 2026
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 DiabetesPHASE1_PHASE2 · RECRUITING · started Apr 7, 2023ClinicalTrials.gov NCT05626712 · fetched Nov 12, 2026
SEC filings12
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 25, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 31, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- S-1/A · FORM S-1/ASEC EDGAR · filed Jun 26, 2026 · fetched Nov 12, 2026
- S-1 · FORM S-1SEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026
- 10-K/A · FORM 10-K/ASEC EDGAR · filed Apr 24, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-KSEC EDGAR · filed Mar 20, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 31, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 19, 2025 · fetched Nov 12, 2026